Global analgin market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The global analgin market is projected to reach USD 1,814.2 million by 2030 from USD 1,611.4 million in 2020, at a CAGR of 3.5%. The growth of the global analgin market can be attributed to factors such as increasing prevalence of chronic diseases and rising demand for pain relief drugs across the globe.
The global analgin market has been segmented on the basis of type into 99% or more and 97%99%. The 99% or more segment accounted for over 50% share in 2019 and is expected to maintain its dominance throughout the forecast period owing to its high purity level which makes it suitable for injection purposes as well as other applications such as tablet formulation and nasal drops formulation among others.
The application segmentation includes tablet, injection, nasal drops and enemas among others which are used for various purposes such as pain relief treatment among others.
- Analgin is a pain reliever and fever reducer.
- It is used to treat mild to moderate pain, such as headaches, toothaches, menstrual cramps, and arthritis pain.
- It can also be used for the treatment of fever in adults and children over 2 years old who are not taking aspirin or other anti-inflammatory drugs.
- The drug is available in tablet form or as an injection.
- The drug has been on the market since 1949.
Industry Growth Insights published a new data on “Analgin (CAS 68-89-3) Market”. The research report is titled “Analgin (CAS 68-89-3) Market research by Types (99% or More, 97% -99%, Others), By Applications (Tablet, Injection, Nasal Drops, Enemas), By Players/Companies Shandong Xinhua Pharmaceutical, Wuhan Honor Bio-Pharm, Hebei Jiheng (Group) Pharmaceutical, WuhanWuyao Pharmaceutical, Zhejiang Haisen Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Analgin (CAS 68-89-3) Market Research Report
By Type
99% or More, 97% -99%, Others
By Application
Tablet, Injection, Nasal Drops, Enemas
By Companies
Shandong Xinhua Pharmaceutical, Wuhan Honor Bio-Pharm, Hebei Jiheng (Group) Pharmaceutical, WuhanWuyao Pharmaceutical, Zhejiang Haisen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Analgin (CAS 68-89-3) Market Report Segments:
The global Analgin (CAS 68-89-3) market is segmented on the basis of:
Types
99% or More, 97% -99%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Injection, Nasal Drops, Enemas
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shandong Xinhua Pharmaceutical
- Wuhan Honor Bio-Pharm
- Hebei Jiheng (Group) Pharmaceutical
- WuhanWuyao Pharmaceutical
- Zhejiang Haisen Pharmaceutical
 Market Overview.svg)
Highlights of The Analgin (CAS 68-89-3) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% or More
- 97% -99%
- Others
- By Application:
- Tablet
- Injection
- Nasal Drops
- Enemas
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Analgin (CAS 68-89-3) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Analgin is a white to off-white crystalline solid with a characteristic odor. It is used as an intermediate in the production of other chemicals.
Some of the key players operating in the analgin (cas 68-89-3) market are Shandong Xinhua Pharmaceutical, Wuhan Honor Bio-Pharm, Hebei Jiheng (Group) Pharmaceutical, WuhanWuyao Pharmaceutical, Zhejiang Haisen Pharmaceutical.
The analgin (cas 68-89-3) market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Analgin (CAS 68-89-3) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Analgin (CAS 68-89-3) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Analgin (CAS 68-89-3) Market - Supply Chain
4.5. Global Analgin (CAS 68-89-3) Market Forecast
4.5.1. Analgin (CAS 68-89-3) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Analgin (CAS 68-89-3) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Analgin (CAS 68-89-3) Market Absolute $ Opportunity
5. Global Analgin (CAS 68-89-3) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
5.3.1. 99% or More
5.3.2. 97% -99%
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Analgin (CAS 68-89-3) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
6.3.1. Tablet
6.3.2. Injection
6.3.3. Nasal Drops
6.3.4. Enemas
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Analgin (CAS 68-89-3) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Analgin (CAS 68-89-3) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Analgin (CAS 68-89-3) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Analgin (CAS 68-89-3) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Analgin (CAS 68-89-3) Demand Share Forecast, 2019-2026
9. North America Analgin (CAS 68-89-3) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
9.4.1. Tablet
9.4.2. Injection
9.4.3. Nasal Drops
9.4.4. Enemas
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
9.7.1. 99% or More
9.7.2. 97% -99%
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Analgin (CAS 68-89-3) Demand Share Forecast, 2019-2026
10. Latin America Analgin (CAS 68-89-3) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
10.4.1. Tablet
10.4.2. Injection
10.4.3. Nasal Drops
10.4.4. Enemas
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
10.7.1. 99% or More
10.7.2. 97% -99%
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Analgin (CAS 68-89-3) Demand Share Forecast, 2019-2026
11. Europe Analgin (CAS 68-89-3) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Analgin (CAS 68-89-3) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
11.4.1. Tablet
11.4.2. Injection
11.4.3. Nasal Drops
11.4.4. Enemas
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
11.7.1. 99% or More
11.7.2. 97% -99%
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Maket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Analgin (CAS 68-89-3) Demand Share, 2019-2026
12. Asia Pacific Analgin (CAS 68-89-3) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Analgin (CAS 68-89-3) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
12.4.1. Tablet
12.4.2. Injection
12.4.3. Nasal Drops
12.4.4. Enemas
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
12.7.1. 99% or More
12.7.2. 97% -99%
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Analgin (CAS 68-89-3) Demand Share, 2019-2026
13. Middle East & Africa Analgin (CAS 68-89-3) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Analgin (CAS 68-89-3) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Analgin (CAS 68-89-3) Market Size and Volume Forecast by Application
13.4.1. Tablet
13.4.2. Injection
13.4.3. Nasal Drops
13.4.4. Enemas
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Analgin (CAS 68-89-3) Market Size and Volume Forecast by Type
13.7.1. 99% or More
13.7.2. 97% -99%
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Analgin (CAS 68-89-3) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Analgin (CAS 68-89-3) Market: Market Share Analysis
14.2. Analgin (CAS 68-89-3) Distributors and Customers
14.3. Analgin (CAS 68-89-3) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shandong Xinhua Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Wuhan Honor Bio-Pharm
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hebei Jiheng (Group) Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. WuhanWuyao Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Zhejiang Haisen Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
